Gwen Marcellana 🫀

Cardio-Oncology Clinical Fellow at Royal Brompton Hospital. Former Chief Fellow of the Heart Institute SLMC Global City. Mother of Cats. Likes to run. 🏃🏻‍♀️

[Gwen Marcellana 🫀 @thecardiofellow]

Honored and humbled to share that two of my abstracts have been accepted for presentation at the ESC Congress 2026 in Munich. Grateful for the opportunity and looking forward to contributing to the scientific discussions. ☺️✨ https://t.co/0e0LUG3mOm

[Gwen Marcellana 🫀 @thecardiofellow]

I have joined a fundraising for Ovarian Cancer Action. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving https://t.co/CeLnj9xBq5

[Gwen Marcellana 🫀 @thecardiofellow]

I have joined the fundraising for Diabetes UK. Check out their @JustGiving page and please donate if you can. Thank you! #JustGiving https://t.co/E72mqWSqGv

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Real-world cases drive progress in #cardiooncology

📣 Clinical case submissions for #ESCardioOnco26 close tomorrow,
5 February 2026

Share your experience & help move the field forward: https://t.co/P0o8QV30NH

#ESCCardioOnco @escardio @TeresaLpezFdez1

[Clara Llamedo, MD @LlamedoClara]

We look forward to you joining the second edition of the COOL webinar, insights into the latest advances in cardio-oncology research. Register online for free. @ESCardioOnco @slumberbell @Massimi78530343 @escardio

https://t.co/VN4rznIJPm

[International Cardio-Oncology Society @ICOSociety]

📰 HOT OFF THE PRESSES 📰

Immune Checkpoint Inhibitor (#ICIs) treatments are known to potentially cause harm to the heart, particularly through conditions like #myocarditis.

Today in @JAMAOnc, we stressed the importance of interdisciplinary collaboration as the best way to mitigate effects and protect the #hearts of #cancer patients.

Read the positioning statement: https://t.co/2SktP5Q75j

[JACC Journals @JACCJournals]

💔🎗️ #Anthracyclines save young lives but can harm the heart
📊 New intl guidelines outline 🔑 dose risks:
➡️ Daunorubicin ≈ 0.6× doxorubicin
⬆️ Mitoxantrone ≈ 10.5× higher

Personalized dosing = stronger hearts after cancer therapy https://t.co/Vm5nABgDt0 #JACCCardioOnc #cvPed

[Keith Siau @drkeithsiau]

Iron Man ⚡️

[Mujeeb Zubair, MD @MujeebZubair]

Ball in cage mechanical valve in motion. A remarkable piece of cardiac surgery history.

[JAMA Oncology @JAMAOnc]

A validated risk model accurately predicted 10-year risk of heart failure or cardiomyopathy in women treated for early-stage breast cancer, integrating clinical and treatment variables available at diagnosis.

https://t.co/oByvJ4MMRO

[Pablo Corral MD @drpablocorral]

👉Oral PCSK9 Inhibitors: A New Frontier in Lipid Management

👆A meta-analysis including >1,000 patients shows that oral PCSK9 inhibitors reduce key atherogenic lipoproteins by a clinically meaningful magnitude:

🔹 LDL-C ↓ 47.8%
🔹 ApoB ↓ 38.7%
🔹 Lp(a) ↓ 19.8%
🔹 Triglycerides ↓ 11.6%

Importantly, these agents demonstrated no increase in serious adverse events versus placebo.

💊 Oral PCSK9 inhibitors could transform lipid management — combining potent LDL-lowering efficacy with the convenience of oral dosing, potentially improving accessibility and adherence for patients with ASCVD or familial hypercholesterolemia.

🔗https://t.co/PZGjR3RJu0

@society_eas
@nationallipid

[Curiosity @CuriosityonX]

Golden Saturn

[Keith Siau @drkeithsiau]

There’s cardiomegaly and there’s this 🤯

[Gwen Marcellana 🫀 @thecardiofellow]

@drkeithsiau Oh my

[PCRonline 🫀 @PCRonline]

"I've done it!" On 16 September 1977, Andreas Grüntzig made history: he carried out the first #angioplasty, and changed the lives of millions of patients forever.

Standing on the shoulders of the giants that came before him, his vision and determination drove an entire new field of cardiology: Interventional Cardiology

Listen to this description of his incredible journey by Jean Marco, who knew him and was also a pioneer in the field. Jean Marco carried out his first angioplasty in 1979 and was inspired by Gruntzig's example to launch a LIVE demonstration Course in 1982.

This ultimately paved the way for the first PCR Course in 1989, founded with Jean Fajadet in Toulouse, and gave birth to PCR as we know it today.

From the legs to the coronaries: How Andreas Grüntzig reached his dream 📺 🎧 https://t.co/IZxUFqLjEm
(interviewed by @kiadeb87 )

More about the history of PCR here 🔗 https://t.co/eIAE7rz8zj

#interventionalcardiology #medicalhistory #interventionalcardiologist #cathlab

[American Society of Echocardiography @ASE360]

Team Asia has won the Echo World Cup at #ASE2025! 🌎

[Gwen Marcellana 🫀 @thecardiofellow]

@thurlcledera @RadiologyCTI Congratulations doc!!!

[JACC Journals @JACCJournals]

CVD is the leading cause of death in women, with risk increasing after #menopause. This review explores how the menopause transition, including hormone changes, sleep issues, and mental health shifts, can alter #CVD risk. https://t.co/26phPESk1r

#JACCAdvances @GarimaVSharmaMD

[American Society of Echocardiography @ASE360]

🫀NEW GUIDELINE🫀
Read our newest #ASEGuideline, "Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis!" https://t.co/bKTTQachMJ

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

♥️Cardiac Rehabilitation is part of GDMT but we seem less willing to write for this life saving prescription.

♥️Especially for women.

♥️Let’s make patients aware & send those who need it to it

Saving lives, one step at a time
#cardiacrehab @SmidtHeart #womenshearts